MannKind Corporation to Present at NobleCon14 – Noble Capital Markets’ Fourteenth Annual Investor Conference

On January 16, 2018 MannKind Corporation (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, reported that its Chief Executive Officer, Michael Castagna, will present at NobleCon14 — Noble Capital Markets’ Fourteenth Annual Investor Conference on Monday, January 29, 2018 at 10:00 Eastern Standard Time at the W Hotel in Fort Lauderdale, Florida (Press release, Mannkind, JAN 16, 2018, View Source [SID1234523147]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A high-definition, video webcast of the presentation will be available the following day on the Company’s web site www.mannkindcorp.com, and as part of a complete catalog of presentations available at Noble Capital Markets’ websites: www.noblecapitalmarkets.com, and www.nobleconference.com. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will be archived on the Company’s website and on the Noble websites for 90 days following the event.